Skip to main content
. 2021 Apr 6;12:630841. doi: 10.3389/fmicb.2021.630841

TABLE 1.

Experimental data and characteristics of rats subjected to BL and HS.

Con
HS
PBS (n = 8 ∼ 10) BL (n = 8 ∼ 10) PBS (n = 8 ∼ 10) BL (n = 8 ∼ 10)
BW pre-gavage, g 266.4 ± 14.43 266.4 ± 13.81 265.3 ± 11.63 265.4 ± 11.09
BW post-gavage, g 309.8 ± 11.01 317.5 ± 12.19 308.2 ± 11.91 319.4 ± 9.91
BW post-heating, g 285.6 ± 12.48 308.7 ± 11.33
BW lose-heating, g 12.6 ± 2.38 10.7 ± 2.65
Tc max, °C 43.1 ± 0.46 42.0 ± 0.58#
Time of HS onset, min 96.9 ± 6.51 113.3 ± 11.09#
ALT, U/L 25.2 ± 8.59 24.5 ± 6.47* 127.9 ± 36.17* 79.8 ± 15.6#
AST, U/L 81.8 ± 10.99 80.3 ± 11.44* 322.6 ± 60.27* 146.9 ± 34.07#
BU, mol/L 4.8 ± 2.26 5.3 ± 0.98* 19.5 ± 5.50* 14.2 ± 2.90#
CREA, μmol/L 6.7 ± 1.77 8.2 ± 1.44* 58.2 ± 18.17* 27.5 ± 7.054#
CK, U/L 291.3 ± 172.90 462.2 ± 116.10* 1631 ± 1002.00* 808.9 ± 336.60#
TNF-α, pg/ml 1.5 ± 0.31 1.1 ± 0.66* 3.3 ± 0.65* 1.8 ± 0.41#
IL-1β, pg/ml 5.9 ± 4.39 8.6 ± 4.54* 34.7 ± 6.69* 28.1 ± 3.94#
IL-6, pg/ml 4.0 ± 2.92 3.2 ± 1.92* 40.7 ± 10.87* 20.8 ± 4.41#
D-Lactate, μmol/mL 0.2 ± 0.03 0.2 ± 0.041* 0.7 ± 0.13* 0.3 ± 0.03#
I-FABP, pg/mL 216.3 ± 80.17 212.7 ± 63.04* 754.7 ± 266.2* 368.9 ± 117.3#
Endotoxin, EU/mL 0.1 ± 0.01 0.1 ± 0.01* 0.8 ± 0.13* 0.6 ± 0.13#
FITC-4kD, μmol/mL 0.1 ± 0.03 0.1 ± 0.04* 1.8 ± 0.86* 0.9 ± 0.43#

Data are shown as means ± SD; sample sizes are indicated in (n); BW, body weight; Tc max, mean value and SD of the maximum Tc during the heating period. Time of HS onset, the time from the beginning of heating to Tc reaching the standard of HS onset or to the end of the heating period in the BL group. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BU, blood urea; CK, creatine kinase; CREA, creatinine; I-FABP, intestinal fatty acid-binding protein; FITC-4kD, 4-kDa fluorescein isothiocyanate. * vs. Con + PBS; # vs. HS + PBS.